Featured
- Get link
- Other Apps
Optic nerve glioma market Analysis, Future Prospects, Regional Trends and Potential of the Market 2030
Overview:
The Optic Nerve Glioma Market is
expected to reach USD 619.7 Million by 2030 at 6.5% CAGR during the forecast
period 2022-2030. The market may register strong growth in the coming years as
new and effective treatments are making grounds. Growing awareness among
patients regarding such diseases is expected to increase the expansion scope
for the global optic nerve glioma market.
However, treatment for this disease includes radiation therapy,
which can affect the brain and it also incurs high cost. Market Research Future
(MRFR) believes that these factors could emerge as market deterrents in the
coming years.
Segmentation:
The global study on the optic nerve glioma market includes a
detailed understanding of segments like types, diagnosis, treatment and end
users. This will help provide data and a closer look at various aspects that
can influence the market outcome later.
By types, the review of the optic nerve glioma market includes
segments like malignant optic nerve glioma and benign optic nerve glioma.
By diagnosis, the report on the optic nerve glioma market
studied segments like a neurological exam, Magnetic Resonance Imaging (MRI),
Computed Tomography (CT), biopsy, and others. The MRI segment is getting
traction for its ability to provide a comprehensive analysis of symptoms.
By treatment, the report on the optic nerve glioma market
includes segments like surgery, chemotherapy, radiation therapy, and
others.
By end users, the report on the optic nerve glioma market
includes segments like diagnostic centers, pharmacy hospitals and clinics, and
others.
Regional Analysis:
Better infrastructure, expenditure capacity, research scope, and
integration of advanced technologies are expected to boost the American optic
nerve glioma market. This region displays the potential to lead the market and
introduce changes in the coming years. Asia Pacific would record growth as its
massive population would back the treatment procedure.
Competitive Landscape:
The Key Optic Nerve Glioma Market player are Sigma-Aldrich Co., Thermo Fisher Scientific
Inc., Emcure Pharmaceuticals ltd., Taj Pharmaceuticals Limited, Pfizer Inc.,
Teva Pharmaceutical Industries Ltd, Novartis International AG, Philips
Healthcare, GE Healthcare, Siemens Healthcare, Toshiba Medical Systems
Corporation, Shimadzu Corporation, and others are companies with the ability to
impact the global output significantly. This depends mostly on the strategic
developments made by these companies to boost their own market stand.
Industry News:
In May 2020, a new study by the researchers from the Washington
School of Medicine in St. Louis revealed that children with the genetic
condition neurofibromatosis type 1 (NF1) are showing chances of developing
brain and nerve tumors. In fact, this tumor has the potential to turn the child
suffering from such symptoms blind. However, new findings, published in the May
1 issue of Nature Communications, revealed that a new way of treatment could
slow down the growth of this cancerous cell in mice and researchers believe
that this treatment can be effective for low-grade brain tumors in people with
NF1.
In April 2020, the US Food and Drug Administration approved the
use of selumetinib for children of 2 years of age and older with
neurofibromatosis type 1 (NF1) as the studies revealed positive signs for the
phase 2 trial in the March 18 issue of the New England Journal of Medicine. The
medicine is expected to be effective for the treatment of diseases like optic
pathway glioma.
However, the recent COVID-19 pandemic could impact the global
market for optic nerve glioma to some extent as the countermeasures for the
pandemic have imposed some restraints in providing facilities to treat such
diseases.
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Popular Posts
COVID-19 Diagnostics Market Trends, Overview, Competitors Strategy, Regional Analysis and Growth Foresight
- Get link
- Other Apps
Biologics Market Company Profiles, Market Segments, Landscape, Demand and Forecast – 2030
- Get link
- Other Apps
Comments
Post a Comment